Françoise Bordier

RPR 119990, a novel alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid antagonist: synthesis, pharmacological properties, and activity in an animal model of amyotrophic lateral sclerosis.

Thierry Canton, Böhme Ga, Alain Boireau et al. · PubMed · 2001 · 68 citations

Medicine, Neuroscience, Pharmacology +17

RPR 119990, a Novel α-Amino-3-hydroxy-5-methyl-4-isoxazolepropionic Acid Antagonist: Synthesis, Pharmacological Properties, and Activity in an Animal Model of Amyotrophic Lateral Sclerosis

Thierry Canton, Georg Andrees Böhme, Alain Boireau et al. · Journal of Pharmacology and Experimental Therapeutics · 2001 · 46 citations

Medicine, Neuroscience, Pharmacology +12

The protective effect of riluzole in the MPTP model of Parkinson's disease in mice is not due to a decrease in MPP+ accumulation

Alain Boireau, Pierre Dubédat, Françoise Bordier et al. · Neuropharmacology · 2000 · 32 citations

Medicine, Neuroscience, Pharmacology +16

Thalidomide reduces MPTP-induced decrease in striatal dopamine levels in mice

Alain Boireau, Françoise Bordier, Pierre Dubédat et al. · Neuroscience Letters · 1997 · 29 citations

Life Sciences, Neuroscience, Pharmacology +12

Neuroprotective effects of RPR 104632, a novel antagonist at the glycine site of the NMDA receptor, in vitro

Alain Boireau, C. Malgouris, Marie‐Claude Burgevin et al. · European Journal of Pharmacology · 1996 · 17 citations

Life Sciences, Neurobiology, Neuroscience +17